Compare, Analyse ALEMBIC PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   MYLAN
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
MYLAN
Dec-18
ALEMBIC PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6643,521-   
Low Rs4121,938-   
Sales per share (Unadj.) Rs208.71,620.4-  
Earnings per share (Unadj.) Rs31.044.0-  
Cash flow per share (Unadj.) Rs37.1347.4-  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.21,752.9-  
Shares outstanding (eoy) m188.52514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.7 153.1%   
Avg P/E ratio x17.462.0 28.0%  
P/CF ratio (eoy) x14.57.9 184.6%  
Price / Book Value ratio x3.71.6 239.6%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4611,404,514 7.2%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m7,4670-   
Avg. sales/employee Rs ThNM23,819.4-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM646.8-  
INCOME DATA
Net Sales Rs m39,347833,681 4.7%  
Other income Rs m940-   
Total revenues Rs m39,441833,681 4.7%   
Gross profit Rs m8,736215,726 4.0%  
Depreciation Rs m1,152156,098 0.7%   
Interest Rs m18440,097 0.5%   
Profit before tax Rs m7,49319,531 38.4%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568-3,107 -50.4%   
Profit after tax Rs m5,84422,638 25.8%  
Gross profit margin %22.225.9 85.8%  
Effective tax rate %20.9-15.9 -131.5%   
Net profit margin %14.92.7 546.9%  
BALANCE SHEET DATA
Current assets Rs m19,577465,527 4.2%   
Current liabilities Rs m14,896339,420 4.4%   
Net working cap to sales %11.915.1 78.7%  
Current ratio x1.31.4 95.8%  
Inventory Days Days9084 107.4%  
Debtors Days Days4593 48.6%  
Net fixed assets Rs m27,097161,720 16.8%   
Share capital Rs m377444 84.9%   
"Free" reserves Rs m26,8110-   
Net worth Rs m27,188901,890 3.0%   
Long term debt Rs m4,993973,429 0.5%   
Total assets Rs m47,7782,419,220 2.0%  
Interest coverage x41.71.5 2,804.3%   
Debt to equity ratio x0.21.1 17.0%  
Sales to assets ratio x0.80.3 239.0%   
Return on assets %12.62.6 486.5%  
Return on equity %21.52.5 856.3%  
Return on capital %23.63.2 742.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m13,3880-   
CASH FLOW
From Operations Rs m8,120173,239 4.7%  
From Investments Rs m-7,556-89,545 8.4%  
From Financial Activity Rs m590-80,705 -0.7%  
Net Cashflow Rs m1,1531,435 80.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.98 Rs / USD

Compare ALEMBIC PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC PHARMA With: DR. REDDYS LAB  PIRAMAL ENTERPRISES  GLENMARK PHARMA  ORCHID PHARMA  TORRENT PHARMA  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views On News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ALEMBIC PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS